Castle Biosciences Inc is a molecular diagnostics company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CSTL is expected to report earnings to rise 333.29% to -30 cents per share on November 09
Q3'26
Est.
$-0.30
Q2'26
Beat
by $0.33
Q1'26
Est.
$-0.49
Q4'25
Beat
by $0.24
Q3'25
Beat
by $0.50
The last earnings report on July 30 showed earnings per share of -7 cents, beating the estimate of -40 cents. With 76.12K shares outstanding, the current market capitalization sits at 989.50M.